We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:TGTX

TG Therapeutics (TGTX)

Nasdaq • TGTX • US88322Q1085

Market Closed

Trading Signals

ORTEX Data Highlights

As of Nov 2, 2026, ORTEX estimates 21.5% of free float is sold short, 18.3 days to cover, cost to borrow 0.43%.

Market Cap

8.62b USD | # 1775 in US

Volume

1.81m shares | 98.51m USD

Shares Outstanding

141.85m

Free Float Shares

95.34% | 135.24m

DB:NKB2|

LSE:0VGI|

News

TGTX key data

TG Therapeutics (Nasdaq: TGTX) has a market capitalization of $8.62B. Last close $60.75 (as of 2026-11-04); 52-week range $26.76 to $63.60. ORTEX data as of 2026-11-02: short interest is 21.5% of free float, 18.3 days to cover and the average cost to borrow is 0.43%.

TGTX news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.